Background We investigated safety-related outcomes of hepatobiliary pancreatic (HBP) surgeries performed after establishment of the Japanese Society of HepatoBiliary-Pancreatic Surgery (JSHBPS) board certification system for expert surgeons. Methods We analyzed post-HBP surgery mortality data obtained from annual safety reports provided by board-certified training institutions between 2012 and 2015.
Introduction
Despite tremendous advances in hepatobiliary pancreatic (HBP) surgery in recent years, the operative mortality rate remains unsatisfactory, especially in comparison to that of gastrointestinal surgery. Across clinical fields, the matter of treatment safety has received increased attention, and HBP surgery has been subject to especially high levels of scrutiny. In response to the growing demands on medical professionals to meet our commitment to society, the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) has established a board certification system for the purpose of cultivating surgeons who can perform high-level HBP surgeries safely and reliably. With the validity of the system recently established, we investigated the safety-related outcomes of initiatives related to the JSHBPS board certification system for expert surgeons and report our findings herein.
Methods

Initiatives related to the JSHBPS board certification system
Following the declaration in 2003 that the JSHBPS would establish a board certification system aimed at cultivating expert surgeons capable of performing high-level HBP surgeries safely and confidently [1, 2] , the following steps were taken.
Defining high-level HBP surgery
The JSHBPS first designated 28 surgeries as high-level HBP surgeries. These, as shown on Table 1 , are of four categories: hepatobiliary surgery, hepatopancreatic surgery, pancreatic surgery, and HPB surgery requiring vascular resection and reconstruction. The hepatobiliary surgeries are of 11 types, hepatopancreatic surgery is of a single type, the pancreatic surgeries are of 11 types, and the HPB surgeries requiring vascular resection and reconstruction are of five types.
Establishing a system for board certification of instructors
A program designed to board certify instructors was begun in 2008. To qualify as a board-certified instructor, surgeons must have performed 100 or more high-level HBP surgeries as an operator or teaching first assistant. This instructor certification program concluded in 2014 because by that time an adequate number of instructors had been board certified and were available ( Table 2) .
Establishing a system for board certification of training institutions
Starting in 2008, a system was put into place for recognition of institutions where more than 50 high-level HBP surgeries are performed annually as board-certified A training institutions (A training institutions) and for recognition of institutions where more than 30 high-level HBP surgeries are performed annually as board-certified B training institutions (B training institutions) ( Table 2) .
Establishing a system for board certification of expert surgeons Board certification of expert surgeons was also begun in 2011. To achieve board-certified expert surgeon status, applicants must first perform 50 or more high-level HBP surgeries at a board-certified training institution while training under a board-certified instructor. After earning the required number of credits in the stipulated training program, the applicants must submit videos of specific surgeries for JSHBPS assessment of their surgical skills, and they must pass this evaluation (Table 2 ) [1] [2] [3] [4] .
Establishing a safety management commission
The JSHBPS Safety Management Commission was established in 2011. Since 2012, all board-certified training institutions have been required to turn in safety reports, which are used in turn as a basis for reports and calls for attention at the JSHBPS Annual Meetings. Since 2014, the JSHBPS Safety Management Commission has provided feedback to each board-certified training institution on how it ranks in relation to the range of mortality rates reported by all boardcertified training institutions. Since 2015, the Commission has required board-certified institutions with a 90-day mortality rate of 5% or more to provide reports that include the following case details: the patient's preoperative status, the surgical procedure performed, the clinical course including postoperative complications, and the cause of death. On the basis of the furnished reports, the Commission provides the reporting institutions with guidance concerning safe practices and case management. The Commission also conducts site visits when necessary.
Surgical performance reviews A and B training institutions are now required to provide an annual report detailing the surgeries performed between January 1 and December 31 of the previous calendar year. These reports are to include details of all high-level HBP surgeries (Table 1 ) and of limited hepatic resection and left lateral sectionectomy, extrahepatic bile duct resection (with bilioenteric anastomosis) for conditions other than congenital biliary dilatation, Frey's procedure or pancreatojejunal anastomosis, pancreatic tumor enucleation, and resection of the pancreas body and tail without lymph node dissection. Overall, the report summarizes the number of specific HBP surgeries performed at the institution, the number of patients who died within 30 days of the surgery, and the number of patients who were hospitalized for more than 30 days and died within 90 days.
Data collection and statistical analysis
To assess safety outcomes of the JSHBPS board certification system for expert surgeons, we first tallied the number of training institutions certified, the number of instructors certified, and the number of expert surgeons certified between 2012 and 2015. We also tallied the number of HBP surgeries performed at board-certified institutions each year (2012-2015) for 17 specific HBP diseases. The total number of HBP surgeries was broken down according to the 23 specific HBP surgeries, i.e. the 11 hepatobiliary surgeries, the hepatopancreatic surgery, and the 11 pancreatic surgeries. We then calculated and examined post-HBP surgery 90-day mortality rates over the 4-year period spanning 2012-2015. Mortality rates were compared between years, between A and B institutions, between the types of surgical procedures performed, and between disease types. Trends were assessed by Cochran-Armitage test, and differences in mortality rates between surgical procedures at each boardcertified institution were analyzed by chi-square test. A P value of <0.05 was considered significant.
Because the study conducted was retrospective and did not involve human subjects but was, rather, an analysis of de-identified data collected from JSHBPS-certified training institutions, IRB approval was neither required nor obtained. Table 3 .
Results
Board
The numbers of board-certified instructors and the numbers of board-certified expert surgeons are shown on Table 2 Requirements for application to the JSHBPS board certification system
For recognition as a board-certified training institution (HBP field)
Current status as a board-certified training institution in gastroenterology qualified by the JSGS Employing at least one board-certified instructor or one boardcertified expert surgeon Performing 50 or more high-level HBP surgeries per year (for a board-certified A training institution) Performing 30 or more high-level HBP surgeries per year (for a board-certified B training institution) For recognition as a board-certified instructor (HBP field)
Current status as a board-certified surgeon qualified by the JSS Current status as a board-certified surgeon in gastroenterology qualified by the JSGS Experience performing 100 or more high-level HBP surgeries as an operator For recognition as a board-certified expert surgeon (HBP field)
Current status as a board-certified surgeon qualified by the JSS Current status as a board-certified surgeon in gastroenterology qualified by the JSGS Experience performing 50 or more high-level HBP surgeries as an operator during 3-7 years' training at a board-certified training institution (HBP field) Experience performing 10 or more high-level HBP surgeries as a teaching first assistant during 3-7 years' training at a boardcertified training institution Video review HBP hepatobiliary pancreatic, JSGS Japanese Society of Gastroenterological Surgery, JSHBPS Japanese Society of Hepato-BiliaryPancreatic Surgery, JSS Japan Surgical Society Cited from Ref. [3] Table 4 . By 2014, 779 instructors had been certified. Board-certified instructors are required to renew their certification every 5 years, and at present, there are 642 board-certified instructors. To date, 185 expert surgeons have been board certified [4] .
Number of surgeries per HBP disease and post-HBP surgery mortality
The surgeries performed at board-certified training institutions over the 4-year period spanning 2012-2015 are shown on Table 5 . Approximately 15,000 HBP surgeries were performed annually, for a 4-year total of 59,846. The greatest number of surgeries was performed for hepatocellular carcinoma, cancer of the head of the pancreas, and metastatic liver tumor (in that order). The number of surgeries performed for hepatocellular carcinoma and cancer of the gallbladder decreased each year, but the number of surgeries performed for hepatic perihilar or proximal bile duct cancer, cancer of the head or tail of the pancreas, intraductal papillary mucinous neoplasia (IPMN), and pancreas transplantation increased or tended to increase.
Post-HBP surgery 90-day mortality rates are shown by disease on Table 6 . Of the total deaths over 4 years, 6.1% occurred subsequent to surgery for perihilar or proximal bile duct cancer and 3.4% subsequent to surgery for gallbladder cancer. Post-hepatic surgery mortality rates differed between hepatic diseases, at 1.8% for intrahepatic cholangiocarcinoma, 1.6% for hepatocellular carcinoma, and 0.6% for metastatic hepatic cancer. The 90-day mortality rate subsequent to pancreatic resection was 1.5% in cases of Ampulla of Vater cancer, 1.3% in cases of pancreas head cancer, and 0.9% in cases of pancreas body or tail cancer. The 90-day mortality rate tended to decrease following surgery for most HBP diseases.
Number of high-level HBP surgeries and post-HBP surgery mortality
The numbers of specific surgeries performed over the 4-year period spanning 2012-2015 along with the associated Tables 7 and 8 . Approximately 13,000 open HBP surgeries were performed annually, for a total of 53,929, and the 90-day mortality rate was 1.69%. The number of surgeries increased each year. With respect to the types of HBP surgery, the greatest number performed over the 4 years were as follows: pancreatoduodenectomy (PD), hepatic sectionectomy, resection of the pancreatic body and tail, right or extended right hepatectomy, and left or extended left hepatectomy (in that order). The number of pancreatic surgeries tended to increase, but among hepatectomies, although there were no marked changes in the number of sectionectomies, the number of right and left hepatectomies tended to decrease.
Overall, 90-day mortality following the various highlevel HBP surgeries decreased. The 90-day mortality rates over the 4-year period were highest after left trisectionectomy, hepatopancreatectomy, recipient liver transplantation surgery, hepatectomy with extrahepatic bile duct resection, and right trisectionectomy (in that order). Ninety-day mortality subsequent to these surgeries decreased, but there was no decrease in the numbers of surgeries performed, with the exception of right trisectionectomy. In addition, although the number of cases was small, we observed an increase in the mortality rates for duodenum-preserving pancreas head resection and recipient pancreas transplantation surgery.
The overall 30-day mortality rate decreased significantly from 0.9% in 2012 to 0.6% in 2015 (P < 0.01). The 90-day mortality rate decreased significantly from 2.1% in 2012 to 1.3% in 2015 (P < 0.01, Fig. 1 ). In 2012, 83 hospitals had a 90-day mortality rate of 0%, and by 2015, the 0% rate included 98 hospitals. The number of hospitals with a 90-day mortality rate of 5% or more also decreased each year -from 30 hospitals in 2012 to eight hospitals in 2015 (Fig. 2) .
The 30-and 90-day mortality rates associated with 23 surgical procedures performed at A and B training institutions are shown on Table 9 . We found significant between-institution differences in 30-day mortality following trisectionectomy, right or extended right hepatectomy, and hepatic segmentectomy. We also found significant between-institution differences in the 90-day mortality rates for right or extended right hepatectomy, PD, and the total high-level HBP surgeries. There was no significant difference in mortality between A and B training institutions in association with any other type of surgery.
Discussion
Due to increased concern regarding treatment safety, the JSHBPS established a system for board certification of expert surgeons who perform high-level HBP surgeries. We believe this system of board certification for expert surgeons to be the strictest of all foreign and domestic board certification systems.
We need to determine, of all HBP surgeries performed in Japan, the percentages performed in A and B training institutions. The National Clinical Database (NCD) was established in Japan in 2010 [5] , and data have been recorded since 2011. The NCD is said to cover 95% or more of surgeries that are performed in Japan [6, 7] . The JSHBPS A and B training institutions represent 17-20% of NCD institutions that have performed high-level HBP surgeries, and the surgeries performed at the JSHBPS A and B training institutions represent 52-58% of NCD high-level HBP surgeries [3, 8] .
Operative mortality rates associated with hepatectomy, hepatectomy requiring biliary reconstruction, and pancreatectomy were lower at the JSHBPS board-certified training institutions than those reported elsewhere [9] [10] [11] [12] [13] [14] [15] [16] [17] . In addition, the annual 30-day and 90-day mortality rates for all high-level HBP surgeries decreased significantly over the 4 years spanning 2011-2015. We believe this decrease can be explained by the safety management initiatives put IPMN intraductal papillary-mucinous neoplasm, MCN mucinous cystadenoma Table 7 Number Number of deaths into place by the JSHBPS, particularly the performance data provided at the JSHBPS Annual Meetings and the feedback provided to the participating institutions. By adopting these measures, institutions have been able to identify high-risk patients for whom surgery is not indicated and instead apply other appropriate treatments. We will need to perform further investigations to verify these observations. However, it became clear that the overall number of HBP surgeries, especially the number of high-level HBP surgeries, did not decrease as a result of these measures. Additionally, our academic society began conducting site visits in 2015 on the basis of details given in the summary reports provided by institutions with a mortality rate of 5% or greater. We believe that continuation of these activities will yield further reductions in mortality rates. Although the overall post-operative mortality rates decreased, rates associated with some HBP surgeries remained high. The physical status of liver transplant recipients differs greatly from that of patients undergoing other types of HBP surgery. The mortality rate for these patients is understandably high. If we exclude liver transplant recipients from our analysis, the hepatic surgeries associated with high mortality rates are left trisectionectomy, right trisectionectomy, and hepatectomy with extrahepatic bile duct resection. Left and right trisectionectomy are high-volume hepatectomies, and hepatectomy with extrahepatic bile duct resection is usually hepatectomy performed on a jaundiced liver. To reduce mortality following these surgeries, we must further investigate and understand the resection threshold for specific hepatic diseases, including jaundiced liver.
When we evaluated pancreatectomies, we found that PD and resection of the pancreas body and tail are performed often, and thus achieving low mortality rates in these cases is an important goal. However, mortality associated with hepatopancreatectomy exceeded 5%.
Tran et al. examined post-operative mortality associated with hepatopancreatectomy and found the rate to be 18.6% for hepatopancreatoduodenectomy [14] . Although we have been able to decrease the mortality rate associated with high-level HBP surgeries overall, we believe that decreasing the mortality rates associated with left and right trisectionectomies, hepatectomy with biliary reconstruction, and PD in particular will be challenging. There are many reports stating that performance of surgery at high-volume centers results in improved mortality rates [18] [19] [20] [21] . Judged by the numbers of HBP surgeries performed and the surgical safety records, our board-certified A and B training institutions actually function as highvolume centers. We found a significant difference between our A and B training institutions in the 30-day mortality rates for right trisectionectomy, right hepatic or extended right hepatectomy, and hepatic segmentectomy. We also found a significant difference between our A and B training institutions in the 90-day mortality rates for right hepatic or extended right hepatectomy and PD and in the overall mortality rate for all HBP surgeries. However, we found no significant difference between our A and B training institutions in the 90-day mortality rates for left and right trisectionectomies, hepatectomy with biliary reconstruction, and hepatopancreatectomy, for which the mortality rates are generally high. In light of these findings, we cannot state definitively that surgical safety does or does not differ between our A and B training institutions. Future detailed analyses are needed.
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